Biotech

All Articles

James Wilson leaving behind Penn to release two new biotechs

.After much more than 30 years, genetics treatment innovator James Wilson M.D., Ph.D., is leaving th...

3 biotechs try to trump the summertime heat by shedding team

.As biotechs try to switch a fresh page in August, a minimum of three firms have shed team in tries ...

venBio lifts $528M for 5th lifestyle scientific researches VC fund

.Pro equity capital organization venBio has actually raised an additional half a billion dollars to ...

Otsuka pays $800M for Jnana as well as its clinical-stage PKU medicine

.Otsuka Drug has actually gotten Boston-based Jnana Therapeutics for $800 million so the Eastern bio...

FibroGen gives up 75% of US personnel as asset fails 2 more trials

.FibroGen is significantly reorganizing its service, laying off 75% of its own united state workers ...

Tracon relax weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has actually made a decision to relax functions full weeks after an injectab...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on fallen short epilepsy drug, touts FDA operate

.Our company already know that Takeda is hoping to find a pathway to the FDA for epilepsy medication...

VBI Injections files for insolvency, seeks resource purchase

.Immunology biotech VBI Injections is turning precariously near the point of no return, along with s...

Celldex anti-cKIT antitoxin reduce hives in another period 2 research study

.It is actually challenging to muscle mass in on a space as affordable as immunology, but Celldex Th...